Posts

Showing posts from October, 2024

A Plasma-based Apolipoprotein ELISA Assay to detect Neuropsychiatric Disorders – Project Proposal (ISSN 2753-8176 (online))

A Plasma-based Apolipoprotein ELISA Assay to detect Neuropsychiatric Disorders – Project Proposal (ISSN 2753-8176 (online)) 1. Ana Pedro 1.Gwyntwr1386 Pharmacy, Regus Chester Business Park, Heronsway, Chester, CH49QR, UK. info@gwyntwr1386.com Protocol title A Plasma-based Apolipoprotein ELISA Assay to detect Neuropsychiatric Disorders Protocol identifying number Version 0.1 Date 14/07/2024 Name and address of the Sponsor and monitor Name and title of the person(s) authorised to sign the protocol and the protocol amendment(s) for the Sponsor Ana Pedro, MPHARM, PhD Name and title of the investigator(s) who is (are) responsible for conducting the study, and the address and telephone number(s) of the study site(s). Ana Pedro, MPHARM, PhD Name(s) and address(es) of the clinical laboratory(ies) and other medical and/or technical department(s) and/or institutions involved in the study Background Information Neuropsychiatric disorders (NDs) are a...